DRDO developed 2-DG drug could be game-changer: Karnataka Health Minister Dr K Sudhakar

The 2-DG (2-deoxy-D-glucose), an anti-COVID-19 therapeutic application of the drug, has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddys Laboratories (DRL), Hyderabad.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news